Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis

@article{Nakamura2010EtanerceptCI,
  title={Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis},
  author={Tadashi Nakamura and Syu-ichi Higashi and Kunihiko Tomoda and Michishi Tsukano and Masahiro Shono},
  journal={Clinical Rheumatology},
  year={2010},
  volume={29},
  pages={1395-1401}
}
The benefit of biological therapies in rheumatoid arthritis (RA) treatment is well known, but their role in amyloid A (AA) amyloidosis secondary to RA is unclear. The aim of this study was to clarify the clinical benefit of etanercept in RA patients with AA amyloidosis. We treated 14 RA patients who had serum amyloid A protein (SAA) 1.3 allele, with biopsy… CONTINUE READING